4//SEC Filing
Ozden Rabia Gurses 4
Accession 0001104659-24-010237
CIK 0001393434other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:02 PM ET
Size
5.7 KB
Accession
0001104659-24-010237
Insider Transaction Report
Form 4
Ozden Rabia Gurses
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-31$4.95/sh−7,764$38,432→ 92,767 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 30, 2024. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $5.04, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0001814883
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 7:02 PM ET
- Size
- 5.7 KB